Pluronic micelles, when functionalized with targeting ligands such as antibodies, peptides, or small molecules, can preferentially target specific receptors on breast cancer cells, such as HER2 or folate receptors [166,167]. This evidence concerns the gene ERBB2 and breast cancer.